Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
44.25
+0.04 (0.09%)
At close: Feb 11, 2026, 4:00 PM EST
44.94
+0.69 (1.56%)
After-hours: Feb 11, 2026, 7:59 PM EST
Royalty Pharma Employees
Royalty Pharma had 100 employees as of December 31, 2025. The number of employees increased by 1 or 1.01% compared to the previous year.
Employees
100
Change (1Y)
1
Growth (1Y)
1.01%
Revenue / Employee
$23,780,000
Profits / Employee
$7,710,000
Market Cap
25.54B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 100 | 1 | 1.01% |
| Dec 31, 2024 | 99 | 10 | 11.24% |
| Dec 31, 2023 | 89 | 14 | 18.67% |
| Dec 31, 2022 | 75 | 9 | 13.64% |
| Dec 31, 2021 | 66 | 15 | 29.41% |
| Dec 31, 2020 | 51 | 16 | 45.71% |
| Dec 31, 2019 | 35 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines AG | 11,000 |
| BioNTech SE | 6,772 |
| Moderna | 5,800 |
| Incyte | 2,844 |
| Genmab | 2,681 |
| Alnylam Pharmaceuticals | 2,230 |
| Insmed | 1,271 |
| Ionis Pharmaceuticals | 1,069 |
RPRX News
- 4 hours ago - Royalty Pharma plc (RPRX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 hours ago - Royalty Pharma Reports Q4 and Full Year 2025 Results - GlobeNewsWire
- 22 days ago - Royalty Pharma to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 - GlobeNewsWire
- 4 weeks ago - Royalty Pharma plc (RPRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Teva Taps Royalty Pharma For $500M To Advance Skin Disease Drug - Benzinga
- 4 weeks ago - Royalty Pharma to Highlight Accomplishments and Provide Business Update at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo - GlobeNewsWire
- 4 weeks ago - Royalty Pharma Announces Dividend Increase - GlobeNewsWire